Mindray Launches BC-700 Series Integrated CBC and ESR Hematology Analyzer for Small-to-Mid Sized Labs

Traditionally, erythrocyte sedimentation rate (ESR) tests, which measure how quickly red blood cells (RBCs) settle in diluted plasma over a specified period of time, are performed on an independent analyzer, and can take up to 60 minutes to get the results. However, there is a need for integrated testing for CBC and ESR. Now, the first all-in-one hematology solution that combines 5-part differential with ESR analysis yields both CBC and ESR results with just one test in merely 1.5 minutes, significantly improving workflow and testing efficiency while benefiting patients with quicker blood test reports.

Mindray (Shenzhen, China) has launched the new BC-700 Series, a revolutionary hematology analyzer series that incorporates both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests. The BC-700 Series, including two open vial models BC-700/BC-720 and two autoloader models BC-760/BC-780, is designed to empower medium-volume laboratories with advanced diagnostics technologies that are applied in the premium products.

Striving to benefit more laboratories worldwide, the BC-700 Series adopts Mindray’s core hematology technology of SF Cube 3D analysis and is built from the same platform as its high-end BC-6000 Series, but in a smaller footprint. In SF Cube technology, target cells are subject to a 3D analysis using bi-angular laser scatter signals and fluorescence. The 3D scattergrams generated with the cellular information can help clinical experts to identify and differentiate cell populations, in particular abnormal clusters, providing a more reliable result to the doctor.

Powered by the SF Cube analysis technology, Mindray has developed many useful hematology parameters. With the new parameter, PLT-H, the BC-700 Series can more easily address the challenges that were previously inadequately met by conventional hematology analyzers, providing an accurate optical platelet count result in every CBC and DIFF test. By using patented reagents with cutting-edge technology, the BC-700 Series also allows the platelet clumps to be de-aggregated, offering laboratories a complete solution for reliable platelet analysis.

"We designed and built this analyzer series, because Mindray believes all labs matter. Every laboratory needs solutions that empower trust and accurate results, and this is what drives us to develop technologies and innovations that go above and beyond your requirements," said Shane Wan, Director of International IVD Product Line, Mindray.

Related Links:
Mindray 

Visit expo >

Gold Member

Chagas Disease Test

CHAGAS Cassette

Verification Panels for Assay Development & QC
Seroconversion Panels

New

Piezoelectric Micropump

Disc Pump

New

Mycoplasma Pneumoniae Virus Test

Mycoplasma Pneumoniae Virus Detection Kit